Search
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
New MSK research provides two examples of computational tools developed at MSK that leverage data about cells’ locations to expand our understanding of cancer.
This is the second regulatory approval of the cell-based immunotherapy for a blood cancer.
Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, to help prevent the disease.
Obtenga más información por parte de un miembro de MSK especialista en la atención oncológica de la comunidad latina sobre las pruebas de detección del cáncer colorrectal para ayudar a prevenir la enfermedad.
Meet Elizabeth Rodriguez, Director of Nursing for the David H. Koch Center for Cancer Care at Memorial Sloan Kettering.
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
MSK is committed to helping people with cancer live healthier, more satisfying lives during and after treatment. So that people don’t just survive cancer — they thrive.
A new study reports a possible way to quantify how efficient the immune system is at detecting cancer, and therefore how likely it is that a person will respond to immunotherapy.
Memorial Sloan Kettering (MSK)’s Department of Marketing & Communications was awarded the Silver Award for Most Effective Media Plan in the 2021 Campaign US Media Awards.